SRPT icon

Sarepta Therapeutics
SRPT

Overview Fund Activity

453 hedge funds and large institutions have $10.7B invested in Sarepta Therapeutics in 2024 Q3 according to their latest regulatory filings, with 57 funds opening new positions, 170 increasing their positions, 155 reducing their positions, and 83 closing their positions.

Holders
453
Holders Change
-28
Holders Change %
-5.82%
% of All Funds
6.55%
Holding in Top 10
8
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-50%
% of All Funds
0.12%
New
57
Increased
170
Reduced
155
Closed
83
Calls
$278M
Puts
$221M
Net Calls
+$57.3M
Net Calls Change
-$268M

Top Buyers

1
Capital International Investors
1
Capital International Investors
California
$782M
2
BlackRock
2
BlackRock
New York
$1.38B
3
Wellington Management Group
3
Wellington Management Group
Massachusetts
$341M
4
CCM
4
Camber Capital Management
Massachusetts
$96.8M
5
Janus Henderson Group
5
Janus Henderson Group
United Kingdom
$544M

Top Sellers

1
EC
1
EcoR1 Capital
California
$0
2
Morgan Stanley
2
Morgan Stanley
New York
$119M
3
PBA
3
Paradigm Biocapital Advisors
New York
$0
4
Norges Bank
4
Norges Bank
Norway
$0
5
Jane Street
5
Jane Street
New York
$5.49M
Name Market Value Shares Shares
Change 		Shares
Change %
BlackRock
1
BlackRock
New York
$1.38B 11,023,314 +698,910 +7%
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.12B 8,967,552 -68,072 -0.8%
Capital International Investors
3
Capital International Investors
California
$782M 6,259,282 +1,938,455 +45%
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$544M 4,358,511 +543,143 +14%
State Street
5
State Street
Massachusetts
$533M 4,270,766 +128,973 +3%
Wellington Management Group
6
Wellington Management Group
Massachusetts
$341M 2,726,613 +665,087 +32%
FCM
7
Farallon Capital Management
California
$322M 2,580,000 +285,000 +12%
ACA
8
Avoro Capital Advisors
New York
$319M 2,555,555 -444,445 -15%
JPMorgan Chase & Co
9
JPMorgan Chase & Co
New York
$275M 2,198,883 +355,114 +19%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$265M 2,118,903 -11,748 -0.6%
T. Rowe Price Investment Management
11
T. Rowe Price Investment Management
Maryland
$243M 1,946,240 -12,395 -0.6%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$212M 1,696,354 +44,306 +3%
Deutsche Bank
13
Deutsche Bank
Germany
$183M 1,463,176 -110,401 -7%
Fidelity Investments
14
Fidelity Investments
Massachusetts
$154M 1,235,742 -624,803 -34%
CC
15
Casdin Capital
New York
$134M 1,073,500 – –
Pictet Asset Management
16
Pictet Asset Management
Switzerland
$131M 1,051,011 +93,793 +10%
O
17
OrbiMed
New York
$119M 954,500 +308,500 +48%
Morgan Stanley
18
Morgan Stanley
New York
$119M 953,104 -1,670,257 -64%
Citadel Advisors
19
Citadel Advisors
Florida
$116M 926,219 +150,398 +19%
Bank of America
20
Bank of America
North Carolina
$97.8M 783,029 +61,628 +9%
CCM
21
Camber Capital Management
Massachusetts
$96.8M 775,000 +625,000 +417%
Jacobs Levy Equity Management
22
Jacobs Levy Equity Management
New Jersey
$94.1M 753,845 +63,437 +9%
Northern Trust
23
Northern Trust
Illinois
$81.9M 655,637 -12,441 -2%
BC
24
Boxer Capital
California
$81.2M 650,000 – –
EAM
25
Erste Asset Management
Austria
$79.4M 636,065 +114,665 +22%
1
2 3 4 5